Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Melissa E. Hogg"'
Autor:
Melissa E. Hogg, Sarwat B. Ahmad, Ahmad Hamad, Amer H. Zureikat, T. Peter Kingham, Jin He, Mary Joe K. Rice, Herbert J. Zeh, Cecilia Chang, Jose M. Pimiento
Publikováno v:
Ann Surg Oncol
PURPOSE: To implement a mastery-based robotic surgery curriculum using virtual reality (VR) and inanimate reality (IR) drills at multiple Complex General Surgical Oncology (CGSO) fellowships. METHODS: A prospective study of curriculum feasibility and
Autor:
Melissa E. Hogg, Jason L. Schwarz
Publikováno v:
Journal of Surgical Oncology. 123:1370-1386
The growth in minimally invasive pancreatic surgery (MIPS) has been accompanied by a recent surge in evidence-based data available to analyze patient outcomes. A small complement of randomized control trials as well as a multitude of observational st
Autor:
Amer H. Zureikat, Mordechai Rabinowitz, Herbert J. Zeh, Savreet Sarkaria, Melissa E. Hogg, Georgios I. Papachristou, John Nasr, Kenneth K. Lee, Jennifer Chennat, Wolfgang H. Schraut, Mazen S. Zenati, Steve J. Hughes, Adam Slivka, Michael K. Sanders, Andres Gelrud, Rohit Das, A. James Moser, Asif Khalid, Alessandro Paniccia, Samer AlMasri
Publikováno v:
Surgical Endoscopy. 36:621-630
Treatment of pancreaticobiliary pathology following Roux-en-Y gastric bypass (RYGB) poses significant technical challenges. Laparoscopic-assisted endoscopic retrograde cholangiopancreatography (LA-ERCP) can overcome those anatomical hurdles, allowing
Autor:
Asif Khalid, Nathan Bahary, Sharon Winters, Lauren Stitt, Adam C. Olson, Richard S. Hoehn, Adam Slivka, Kenneth K. Lee, Ritu Sarkaria, James Ohr, Caroline J. Rieser, Randal E. Brand, Steve Burton, Vikram C. Gorantla, David L. Bartlett, Kenneth E. Fasanella, Jennifer Chennat, Rohit Das, Aatur D. Singhi, Herbert J. Zeh, Anuradha Krishnamurthy, Melissa E. Hogg, John C. Rhee, Susannah G. Ellsworth, Kevin McGrath, Alessandro Paniccia, Amer H. Zureikat
Publikováno v:
Ann Surg Oncol
AIMS: National studies have demonstrated disparities in the treatment and survival of pancreatic cancer patients based on socioeconomic status (SES). This study aimed to identify specific differences in perioperative management and outcomes based on
Autor:
James A. Brown, Richard L. Simmons, Amer H. Zureikat, Mazen S. Zenati, Melissa E. Hogg, Jae P. Jung, Amr I. Al Abbas, Herbert J. Zeh
Publikováno v:
HPB. 23:144-153
Background Cholangitis due to anastomotic stricture of the hepaticojejunostomy (HJ) following pancreaticoduodenectomy (PD), while uncommon, adversely affects postoperative quality-of-life. While prior studies have identified patient-related risk fact
Autor:
Brian A. Boone, Joal D. Beane, Mazen S. Zenati, Herbert J. Zeh, A. James Moser, Melissa E. Hogg, David L. Bartlett, Amr I. Al Abbas, Amer H. Zureikat
Publikováno v:
Ann Surg
OBJECTIVES: This study aims to present the outcomes of our decade-long experience of robotic pancreatoduodenectomy and provide insights into successful program implementation. BACKGROUND: Despite significant improvement inmortality over the past 30 y
Autor:
Amr Al-abbas, Melissa E. Hogg, Caroline J. Rieser, Matthew D. Neal, Amer H. Zureikat, Mazen S. Zenati, Brian A. Boone, Ahmad Hamad, Herbert J. Zeh
Publikováno v:
Annals of Surgical Oncology. 26:1503-1511
Pancreatic ductal adenocarcinoma (PDA) is associated with a hypercoagulable state, resulting in a high risk of venous thromboembolism (VTE). Risk of VTE is well established for patients receiving chemotherapy for advanced disease and during the perio
Autor:
Melissa E. Hogg, Amer H. Zureikat, Mazen S. Zenati, Mark D. Girgis, Ahmad Hamad, Jonathan C. King, Herbert J. Zeh
Publikováno v:
Annals of surgery. 274(3)
OBJECTIVE Compare oncologic outcomes after open and robotic pancreatic resections for pancreatic adenocarcinoma (PDAC). SUMMARY OF BACKGROUND DATA Receipt of adjuvant chemotherapy improves survival after resected PDAC. Complications after pancreatect
Autor:
Nathan Bahary, Caroline J. Rieser, Herbert J. Zeh, Mazen S. Zenati, Kenneth K. Lee, Amer H. Zureikat, Hao Liu, Aatur D. Singhi, Amr Al-abbas, Melissa E. Hogg
Publikováno v:
Ann Surg Oncol
BACKGROUND: Neoadjuvant therapy (NAT) is increasingly utilized for pancreatic cancer, however the added benefit of adjuvant therapy (AT) in this setting is unknown. We hypothesized that the magnitude of CA19-9 response to NAT can guide the need for f
Autor:
Kenneth K. Lee, James W. Marsh, Herbert J. Zeh, Melissa E. Hogg, Randall E. Brand, Georgios I. Papachristou, Kevin McGrath, David L. Bartlett, Marina N. Nikiforova, Adam Slivka, Sara E. Monaco, Allan Tsung, Kenneth E. Fasanella, James F. Pingpank, Abigail I. Wald, Anil K. Dasyam, Jennifer Chennat, Aatur D. Singhi, Amer H. Zureikat, N. Paul Ohori, Asif Khalid
Publikováno v:
Gut
ObjectiveDNA-based testing of pancreatic cyst fluid (PCF) is a useful adjunct to the evaluation of pancreatic cysts (PCs). Mutations in KRAS/GNAS are highly specific for intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (